Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jose Sánchez-Pina"'
Autor:
Amalia Domingo-González, Rafael Alonso Fernández, Ana Jiménez, Teresa De Soto Álvarez, Ana Lerma-Verdejo, Virginia Pradillo, Gonzalo Benzo Callejo, Jose Sánchez-Pina, Elena Landete, Alberto Velasco-Valdazo, Marina Menéndez-Cuevas, Mónica María López Riñón, Andrés Ramírez-López, María-Jesús Blanchard, Elham Askari
Publikováno v:
Frontiers in Hematology, Vol 3 (2024)
IntroductionThe regimen with daratumumab, bortezomib, melphalan, and prednisone (D-VMP) is one of the recommended treatments for newly diagnosed multiple myeloma (NDMM) non-transplant eligible due to the results described in the ALCYONE trial. Howeve
Externí odkaz:
https://doaj.org/article/1dfd52abead747df8910ff8da4c394eb
Autor:
Alejandra Leivas, Antonio Valeri, Laura Córdoba, Almudena García-Ortiz, Alejandra Ortiz, Laura Sánchez-Vega, Osvaldo Graña-Castro, Lucía Fernández, Gonzalo Carreño-Tarragona, Manuel Pérez, Diego Megías, María Liz Paciello, Jose Sánchez-Pina, Antonio Pérez-Martínez, Dean A. Lee, Daniel J. Powell, Paula Río, Joaquín Martínez-López
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 8, Pp 1-11 (2021)
Abstract CAR-T-cell therapy against MM currently shows promising results, but usually with serious toxicities. CAR-NK cells may exert less toxicity when redirected against resistant myeloma cells. CARs can be designed through the use of receptors, su
Externí odkaz:
https://doaj.org/article/1628f0cb7aff4d6990b48e1fdfb3acb4
Autor:
Amalia Domingo-González, Rafael Alonso, Teresa de Soto Álvarez, Ana Lerma, Fernando Martín Moro, Jose Sánchez-Pina, Virginia Pradillo Fernández, Elena Landete, Alberto E. Velasco Valdazo, Marina Menéndez Cuevas, Mónica María López Riñón, Andrés Ramírez López, Alberto López-García, Paula Lázaro del Campo, Fabio Augusto Ruiz Gómez, María Jesús Blanchard, Elham Askari
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S144
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a912e468e058bf97599e335819495089
https://doi.org/10.1016/s2152-2650(22)00528-6
https://doi.org/10.1016/s2152-2650(22)00528-6
Autor:
Rebeca Bailén, José Luis Vicario, Laura Solán, Irene Sánchez-Vadillo, Pilar Herrera, María Calbacho, Raquel Alenda, José Luis López-Lorenzo, Karem Humala, Anabelle Chinea, José Sánchez-Pina, Antonio Balas, Miguel Ángel Moreno, Javier Arzuaga, Virginia Pradillo, Nieves Dorado, Gillen Oarbeascoa, Javier Anguita, José Luis Díez-Martín, Mi Kwon
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundDonor specific antibodies (DSAs) can be responsible for graft failure (GF) in the setting of mismatched hematopoietic stem cell transplantation (HSCT). The aim of our study is to report the experience of the Madrid Group of Hematopoietic Tr
Externí odkaz:
https://doaj.org/article/4a55217db47b4a47ad137de77cd48c12
Autor:
Maria-Teresa Cedena, Estela Martin-Clavero, Sandy Wong, Nina Shah, Natasha Bahri, Rafael Alonso, Carmen Barcenas, Antonio Valeri, Johny Salazar Tabares, Jose Sanchez-Pina, Clara Cuellar, Thomas Martin, Jeffrey Wolf, Juan-Jose Lahuerta, Joaquin Martinez-Lopez
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0237155 (2020)
BackgroundStringent complete response (sCR) is used as a deeper response category than complete response (CR) in multiple myeloma (MM) but may be of limited value in the era of minimal residual disease (MRD) testing.MethodsHere, we used 4-colour mult
Externí odkaz:
https://doaj.org/article/392d740cfca04df7beab13da2e72ab62